MedWatch

Britt Meelby Jensen steps down as CEO of Atos Medical

On the day that Coloplast announces the completion of the acquisition of Atos Medical, Britt Meelby Jensen announces her departure as the Swedish company’s CEO. Seasoned Coloplast leader steps in to fill the position.

Britt Meelby Jensen is stepping down as CEO of Atos Medical | Photo: Atos Medical

After three years at the front of Swedish medtech company Atos Medical, Britt Meelby Jensen has set the date for when she will leave the company, a press release announces.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

China approves Y-mabs drug

Y-mabs’ cancer treatment Danyelza, which is currently licensed to Sciclones, has been approved by the Chinese authorities. Y-mabs will receive double-digit sales royalties.

Further reading

Related articles

Latest news

See all jobs